Thank You To Everyone Who Voted

We are excited to announce the winning donation distribution percentages for these three wonderful charities in honor of Multiple Myeloma Awareness Month!*

Voting closed at 11:59 PM March 31st, 2022.


We Are Your Trusted Pharmacy for Multiple Myeloma Patients

We have created an oncology pharmacy experience unlike any other in the industry, and because of this, we are a trusted partner for many multiple myeloma medications.

Onco360 dispenses these medications to treat Multiple Myeloma: Cyclophosphamide, Ninlaro®Pomalyst®Revlimid®Thalomid®, and Xpovio®. 

This list is a small portion of the comprehensive oncology medications Onco360 can provide. Contact your sales representative for a complete listing.

Brand Name Generic Name Route of Administration
Alkeran Melphalan Oral/intravenous
Adriamycin Doxorubicin Intravenous
Belrapzo, Bendeka, Treandav Bendamustine Intravenous
Cytoxan Cyclophosphamide Oral/intravenous
Darzalex Daratumumab Injectable/intravenous
Decadron Dexamethasone Oral/intravenous
Deltasone >Prednisone Oral
Empliciti Elotuzumab Intravenous
Evomela Melphalan Intravenous
Kyprolis Carfilzomib Intravenous
*Ninlaro Ixazomib Oral
Platinol Cisplatin Intravenous
*Pomalyst Pomalidomide Oral
*Revlimid Lenalidomide Oral
*Thalomid Thalidomide Oral
Toposar Etoposide Intravenous
Velcade Bortezomib Injectable/intravenous
*Venclexta Venetoclax Oral
*Xpovio Selinexo Oral
*Indicates a limited distribution drug


Rx Ordering Made Easy

Onco360 provides easy ordering via e-Prescribe, fax, or by phone, and all prescriptions are shipped free of charge.

Limited Distribution Oncology Medications


Oncomed Dba Onco360 or
NPI# 1679618151

VONJO™ (pacritinib) for Myelofibrosis



Order Forms

*Onco360 donated 5% of the select multiple myeloma cancer product portfolio gross profits during the month of March 2022. The general public had the option to vote for one of three charities. The final donation amount, not exceeding $15,000 was split between the three charities, Be The Match,, and the Leukemia and Lymphoma Society based on the percentage split of votes.